“…The pooled prevalence of NSAIDs varied widely across geographical locations. The pooled estimate of NSAIDs prescribing was highest in South Asia at 83.4% (95% CI 74.8, 89.4; n = 4 studies, I 2 = 3.0%, moderate quality of evidence) (37,47,49,57), followed by Latin America and Caribbean at 68.5% (95% CI 66.8, 70.1; n = 1 study, I 2 = 0%, high quality of evidence) (33), East Asia and Pacific at 46.8% (95% CI 35.0, 58.9; n = 10 studies, I 2 = 31.7%, high quality of evidence) (12,25,32,38,40,51,53,58–60), Europe and Central Asia at 40.2% (95% CI 31.8, 49.3; n = 23 studies, I 2 = 12.2%, moderate quality of evidence) (26,27,28,29,39,42,43,45,46,48,50,52,54–56,61–68), Middle East and North Africa at 34.1% (95% CI 33.9, 34.3; n = 1 study, I 2 = 0%, high quality of evidence) (44), and North America at 32.6% (95% CI 16.9, 53.6; n = 12 studies, I 2 = 11.0%, moderate quality of evidence) (11,30,31,34–36,41,69–73). The stratified analyses results are summarized in Table 3 and the forest plot shown in Supplementary Figure 3, available on the Arthritis Care & Research website at https://doi.org/10.1002/acr.25157.…”